Financials
Income statement
Fiscal date | Mar 2025 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | — | 131.5B | 134.5B | 132.4B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | 3.1B | 1.6B | -3.1B |
Selling general and admin | — | 11.0B | 14.2B | 21.8B |
Other operating expenses | — | 82.0B | 105.3B | -292.7B |
Operating income | — | 18.0B | 14.3B | -3.4B |
Non operating interest income | ||||
Income | — | 575.6M | 466.8M | 799.7M |
Expense | — | 601.8M | 590.5M | 640.2M |
Other income expense | — | — | — | — |
Pretax income | — | 17.1B | 11.1B | 4.2B |
Tax provision | — | 3.8B | 2.5B | 904.8M |
Net income | — | 13.3B | 8.6B | 3.3B |
Basic EPS | 0.1 | — | 0.1 | — |
Diluted EPS | 0.1 | — | 0.1 | — |
Basic average shares | 738.2B | — | 770.6B | — |
Diluted average shares | 738.2B | — | 770.6B | — |
EBITDA | — | 21.2B | 14.2B | 4.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | -123.0M | -30.7M | 60.5M |
Preferred stock dividends | — | 0 | 0 | 0 |